Current pharmacotherapy for cholestatic liver disease

Author： Carey Elizabeth J Lindor Keith D

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2473-2484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current pharmacotherapy for inflammatory bowel disease

By McKaig B.C. Stack W.A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 3-14

Informa Healthcare

Access to resources Recommend Favorite

Current perspectives on pharmacotherapy of Alzheimer's disease

By Chopra Kanwaljit Misra Shubham Kuhad Anurag

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 335-350

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

By Culpitt S.V. Rogers D.F.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1007-1020

Informa Healthcare

Access to resources Recommend Favorite

Current Management of Alcoholic Liver Disease

Current Drug Abuse Reviews, Vol. 7, Iss. 1, 2014-04 ,pp. : 18-28

Bentham Science Publishers

Access to resources Recommend Favorite

Xenobiotic-Sensing Nuclear Receptors CAR and PXR as Drug Targets in Cholestatic Liver Disease

Current Drug Targets, Vol. 10, Iss. 11, 2009-11 ,pp. : 1156-1163

Bentham Science Publishers

Access to resources Recommend Favorite